Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatology Other
    EMEA Recommends Updated Label Warnings for Etoricoxib-Containing Drugs - (DGNews)
    Increased Cancer Risk Following Use of Radium-224 - (DGNews)
    Adalimumab Demonstrates Long-Term Benefit in Ankylosing Spondylitis: Presented at EULAR - (DGDispatch)
    Infliximab Monotherapy Effective for Long-Term Treatment of Spondyloarthritis: Presented at EULAR - (DGDispatch)
    Adalimumab Cuts Uveitis Flares: Presented at EULAR - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatology Other
    • Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
    • Long-Term Data on Abatacept and Rituximab Show Continued Efficacy in Rheumatoid Arthritis
    • Are Rituximab and Abatacept Safe Over the Long Term in Rheumatoid Arthritis?
    • Functional Assessment Effectively Measures Therapeutic Success in Rheumatoid Arthritis
    • Battling Chronic Fatigue Syndrome

      Webcasts/CME archive

       Recent cases - Rheumatology Other
        Sigmoid Sinus Thrombosis Presenting with Posterior Alexia in a Patient with Behcet's Disease And Polycythaemia: A Case Report
        Scleroderma with Crescentic Glomerulonephritis: A Case Report
        Non-Hodgkin's Lymphoma in a Woman with Adult-Onset Still's Disease: A Case Report
        Aggressive Immunosuppressive Treatment of Susac's Syndrome in an Adolescent: Using Treatment of Dermatomyositis as a Model
        Takayasu Arteritis Presenting as Cerebral Aneurysms in an 18 Month Old: A Case Report

        Cases archive
          




        my personal edition > rheumatology other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Measure Aids Chronic Fatigue Syndrome Assessment

        A DGReview of :"Hemodynamics instability score in chronic fatigue syndrome and in non-chronic fatigue syndrome."
        Seminars in Arthritis and Rheumatism

        01/23/2003
        By Anne MacLennan


        A particular and quantifiable abnormality in the cardiovascular reactivity of most patients with chronic fatigue syndrome provides an new objective tool for assessing this disorder, suggest researchers in Israel.

        Using a method they developed of giving numerical expression to degree of blood pressure and heart rate lability, the investigators had previously found this 'haemodynamic instability score' (HIS) in CFS patients differs significantly from that in healthy subjects.

        In the current investigation, they found the large majority of CFS patients exhibit an abnormality which is characterised by HIS values >-0.98. Thus, HIS >-0.98 lends objective criteria to the assessment of CFS, report Dr J E Naschitz and colleagues from the Bnai Zion Medical Center and the Technion-Israel Institute of Technology, Haifa, Israel.

        This study compared the HIS in CFS, non-CFS chronic fatigue and patients with recurrent syncope.

        Twenty patients with CFS, 24 with non-CFS chronic fatigue, 44 with syncope of unknown cause and 21 age and sex-matched healthy controls were all evaluated with a standardised head-up tilt test (HUTT).

        Abnormal reactions (endpoints) on HUTT were classified 'clinical outcomes' (cardioinhibitory or vasodepressor reaction, orthostatic hypotension, postural tachycardia syndrome) and 'HIS endpoint', ie HIS >-0.98.

        Highest incidence of endpoints was noted in patients with CFS (79%), followed by patients with syncope of unknown cause (46%), non-CFS chronic fatigue (35%) and healthy controls (14%).

        Presyncope or syncope during tilt occurred in 38% of CFS patients, 21% of non-CFS chronic fatigue patients and 43% of those with recurrent syncope.

        Average HIS values were: CFS = +2.02 (SD 4.07), non-CFS chronic fatigue = -2.89 (SD 3.64), syncope = -3.2 (SD 3.0) and healthy = -2.48 (4.07).

        Odds ratios for CFS patients to have HIS >-0.98 was 8.8 compared with non-CFS chronic fatigue patients, 14.6 compared with recurrent syncope patients and 34.8 compared with healthy controls.

        The investigators point out the cardiovascular reactivity in patients with CFS has certain features in common with the reactivity in patients with recurrent syncope or non-CFS chronic fatigue, such as the frequent occurrence of vasodepressor reaction, cardioinhibitory reaction, and postural tachycardia syndrome.

        However, apart from these shared responses, most patients with CFS exhibit this particular abnormality, which is characterised by HIS values >-0.98, lending objective criteria to CFS assessment, these authors conclude.
        Semin Arthritis Rheum 2002 Dec;32(3):141-8. "Hemodynamics instability score in chronic fatigue syndrome and in non-chronic fatigue syndrome."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send